1596.0000 3.60 (0.23%)
NSE Oct 10, 2025 15:31 PM
Volume: 63,017
 

1596.00
0.23%
BOB Capital Markets Ltd.
Q1 EBITDA/PAT growth strong at 22%/20% YoY to Rs 1.3bn/Rs 1.1bn, meeting street estimates
Eris Lifesciences Ltd. has an average target of 1581.00 from 3 brokers.
More from Eris Lifesciences Ltd.
Recommended